Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Capsol Technologies establishes Advisory Board to support international expansion

Capsol Technologies ASA, a provider of carbon capture technology to large emitters, today announces an international Advisory Board as part of the company’s global scale-up.The Advisory Board brings together seasoned experts from industry, technology development, commercialization, academia, and government policy. With the recent addition of Chris Barkey, former CTO of the leading energy technology company Baker Hughes, the Advisory Board is now complete.   "I am happy to join as an independent advisory board member for Capsol Technologies, sharing the passion about driving the energy

Form 8.3 - Centamin Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +--------------------------------------------------+---------------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+--------------------------------------------------+---------------------------+|(b) Owner or controller of interests and short |  ||positions disclosed, if different from

Form 8.3 - Anglogold Ashanti Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +--------------------------------------------------------+---------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+--------------------------------------------------------+---------------------+|(b) Owner or controller of interests and short positions|  ||disclosed, if different from 1(a):

AcuCort appoints nomination committee

AcuCort announces today that the nomination committee for the 2025 annual general meeting has been appointed and consists of the company’s three largest owners.After consultation with the company’s largest shareholders in terms of votes, as of September 30, 2024, the nomination committee consists of the following members, with Jan Poulsen newly appointed as a member of the nomination committee: •    Gustaf Albèrt, Aqilion AB, chair of the nomination committe.•    Thomas Nestenius, appointed by Zoya Invest AB•    Jan Poulsen, appointed by Life Science Investment Fund (LSIF) The

Flash Smelting pioneer Eero Mäkinen inducted into National Mining Hall of Fame

Metso Corporation’s press release on November 4, 2024, at 1:00 p.m. EETEero Mäkinen (1886-1953), a pioneer of the Finnish mining industry and one of the key inventors of Flash Smelting, has been inducted into the National Mining Hall of Fame. The induction ceremony took place in Denver, Colorado on November 2, 2024.    Mäkinen played an important role in the development of the modern mining industry in Finland. During his career, he made significant contributions to mining education, research and technology. Mäkinen led Outokumpu as the CEO for three decades, bringing the company to

Arise has completed the divestment of the battery project Pajkölen

Arise AB (publ) (“Arise”) has today completed the divestment of Pajkölen BESS AB to Flower Infrastructure Technologies AB. The divestment was announced on 19 September 2024 and closing was conditional upon certain approvals from authorities that has now been received. For more information about the divestment, see the announcement on 19 September 2024. Halmstad 4 November 2024 ARISE AB (publ)                                                                                        For further information, please contact: Per-Erik Eriksson, CEO Arise AB, +46 702 409 902 Markus

Buybacks of shares by H&M during week 44, 2024

Between 28 October 2024 and 1 November 2024 H & M Hennes & Mauritz AB (publ) (LEI code 529900O5RR7R39FRDM42) has repurchased in total 668,832 own B shares (ISIN: SE0000106270) as part of the share buyback programme initiated by the board of directors. The share buybacks form part of the SEK 1 billion share buyback programme that H&M announced on 26 September 2024. The share buyback programme, which runs between 26 September 2024 and no later than 26 November 2024, is being carried out in accordance with Regulation (EU) No 596/2014 on market abuse (the Market Abuse Regulation – MAR) and

Buyback of Class B shares in Essity during week 44, 2024

Between October 28, 2024, and November 1, 2024, Essity Aktiebolag (publ) repurchased a total of 270,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors.The share purchase is part of the SEK 3bn buyback program announced by Essity on June 17, 2024. The buyback program will extend from June 17, 2024, until the 2025 Annual General Meeting and be implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission’s Delegated Regulation 2016/1052 (Safe Harbour Regulation). The share repurchase

BEWI – Invitation to presentation of results for the third quarter of 2024

BEWI, a leading provider of packaging, components, and insulation solutions, will announce its results for the third quarter of 2024 on Wednesday 6 November 2024. The results will be available from 07:00 am CET at the company's homepage, www.bewi.com and Oslo Børs' news site, www.newsweb.no CEO Christian Bekken and CFO Marie Danielsson will present the results from 10:00 through a live webcast. The link to the webcast will be available from BEWI’s website  www.bewi.com/investors/reports-presentations/. It will be possible to post questions through the webcast, and a recording will be

NKT’s new extrusion tower reaches 200 meters and becomes the second tallest tower in the Nordics

With a height of 200 meters, NKT's new tower has become the second tallest in the Nordics. The tower will not only facilitate the production of power cables to meet the increasing global demand but also serve as a symbolic landmark for the green transition.Press release4 November 2024 The new extrusion tower, equivalent in height to the length of two football fields, has been built to meet the growing global demand for high-voltage power cables essential for the transition to renewable energy. Located at NKT's Swedish facility in Karlskrona the tower will be capable of producing power

Sami Pekki Strengthens Finnish Leadership within Layer Group

Sami Pekki, CEO of Layer Group’s Finnish subsidiary Vainiomäki, has been appointed as Country Manager for Layer Group Finland. In his new role, Sami sees great opportunities to enhance collaboration among the Group's Finnish companies and strengthen ties with Swedish operations. As a third-generation leader of Vainiomäki, Sami has deep roots within the company, which primarily focuses on renovation in painting, construction, and kitchen projects. As Country Manager, Sami has a clear mission: to expand cooperation among Layer Group’s Finnish companies and serve as a bridge between

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 237 – 4 NOVEMBER 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements no. 235/24. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Therese Möllevinge, Head of

CS MEDICA Valued at 17,16 DKK (€2.30 ) per Share Ahead of German IPO, Highlighting Unique Regulatory Position and Growth Potential

NuWays, an independent German financial advisory firm, launched its research report today, highlighting the value of CS MEDICA’s competitive edge as a key player in the rapidly growing alternative medicine space and initiating the coverage with a BUY rating and a EUR 2.30 PT based on a SOTP valuation. The upcoming share spin-off through the IPO of CANNORDIC, is set to unlock the company’s underestimated value amid rising demand for alternative medicine.CS MEDICA, a Danish Med-Tech company at the forefront of developing CBD-infused medical devices offering safe, effective alternatives for

The Next Generation of Aquaporin Inside®

At Aquaporin, we continuously work to improve and develop our membrane technology. Recent advancements in the Aquaporin Laboratory show promising progress in our membrane performance, with the potential to transform energy efficiency reductions beyond today’s standards. Chief Technology Officer Torsten Bak shares his excitement about these developments, stating, “We are seeing some very promising preliminary lab data which we look forward to exploring and building upon. A lot of hard work is coming together now, and we believe this holds great potential.” These developments are

Colzyx will present at the BioStock Life Science Summit, November 20

The seventh edition of the BioStock Life Science Summit will take place in Lund on November 20-21. Chair Jens Hansson will present Colzyx to specialist life science investors and potential partners.The Summit connects innovation and capital, providing small-to-medium size Nordic companies from a wide range of therapeutic areas the platform and opportunity to make their case to both Swedish and international investors as well as top-level potential partners in a unique boutique setting.    Date: November 20 Time: 10:05 Location: Auditorium at Medicon Village, Lund Read more &

Elicera Therapeutics will present at the BioStock Life Science Summit, November 20

The seventh edition of the BioStock Life Science Summit will take place in Lund on November 20-21. CEO Jamal El-Mosleh will present Elicera Therapeutics to industry leaders, specialist investors and potential partners.The Summit connects innovation and capital, providing small-to-medium size Nordic companies from a wide range of therapeutic areas the platform and opportunity to make their case to both Swedish and international investors as well as top-level potential partners in a unique boutique setting.    Date: November 20 Time: 14:30 Location: Auditorium at Medicon Village,

Anatom Holding acquires 4.9% shareholding in BioGaia

BioGaia AB (NASDAQ: BIOG) announces that Anatom Holding AG, a Switzerland-based investment firm, has acquired 4,979,813 class B shares in BioGaia AB following the exit of EQT Public Value fund. This acquisition represents 4.9% of BioGaia’s total shares and 3.7% of the total voting rights. The transaction, which is not subject to any conditions, was completed on October 31, 2024. BioGaia, a global leader in probiotics, welcomes Anatom Holding as a long-term investor. Anatom Holding, an independent investment firm managed by the Kahane Family, specializes in providing strategic capital to

Herantis Pharma will present at the BioStock Life Science Summit, November 20

The seventh edition of the BioStock Life Science Summit will take place in Lund on November 20-21. CEO Antti Vuolanto will present Herantis Pharma to industry leaders, specialist investors and potential partners.The Summit connects innovation and capital, providing small-to-medium size Nordic companies from a wide range of therapeutic areas the platform and opportunity to make their case to both Swedish and international investors as well as top-level potential partners in a unique boutique setting.    Date: November 20 Time: 11:20 Location: Auditorium at Medicon Village, Lund

Initiator Pharma will present at the BioStock Life Science Summit, November 20

The seventh edition of the BioStock Life Science Summit will take place in Lund on November 20-21. CEO Claus Olesen will present Initiator Pharma to industry leaders, specialist investors and potential partners. The Summit connects innovation and capital, providing small-to-medium size Nordic companies from a wide range of therapeutic areas the platform and opportunity to make their case to both Swedish and international investors as well as top-level potential partners in a unique boutique setting.    Date: November 20 Time: 13:15 Location: Auditorium at Medicon Village,

Hamlet BioPharma will present at the BioStock Life Science Summit, November 20

The seventh edition of the BioStock Life Science Summit will take place in Lund on November 20-21. Chair Catharina Svanborg will present Hamlet BioPharma to industry leaders, specialist investors and potential partners. The Summit connects innovation and capital, providing small-to-medium size Nordic companies from a wide range of therapeutic areas the platform and opportunity to make their case to both Swedish and international investors as well as top-level potential partners in a unique boutique setting.  Date: November 20 Time: 13:30 Location: Auditorium at Medicon Village,

Infonomy will present at BioStock Life Science Summit on November 20

The seventh edition of the BioStock Life Science Summit will take place in Lund on November 20-21. Chair Jonas Källmén will present Infonomy to industry leaders, specialist investors and potential partners. The Summit connects innovation and capital, providing small-to-medium size Nordic companies from a wide range of therapeutic areas the platform and opportunity to make their case to both Swedish and international investors as well as top-level potential partners in a unique boutique setting.    Date: November 20 Time: 13:50 Location: Auditorium at Medicon Village, Lund

Lipum will present at the BioStock Life Science Summit, November 21

The seventh edition of the BioStock Life Science Summit will take place in Lund on November 20-21. CEO Ola Sandborgh will present Lipum to industry leaders, specialist investors and potential partners.The Summit connects innovation and capital, providing small-to-medium size Nordic companies from a wide range of therapeutic areas the platform and opportunity to make their case to both Swedish and international investors as well as top-level potential partners in a unique boutique setting.    Date: 21 November Time: 09:50 Location: Auditorium at Medicon Village, Lund Read more

ExpreS2ion Biotech will present at the BioStock Life Science Summit, November 21

The seventh edition of the BioStock Life Science Summit will take place in Lund on November 20-21. CEO Bent U. Frandsen will present ExpreS2ion Biotech to industry leaders, specialist investors and potential partners.The Summit connects innovation and capital, providing small-to-medium size Nordic companies from a wide range of therapeutic areas the platform and opportunity to make their case to both Swedish and international investors as well as top-level potential partners in a unique boutique setting.    Date: 21 November Time: 10:50  Location: Auditorium at Medicon Village,

Cellevate will present at the BioStock Life Science Summit, November 21

The seventh edition of the BioStock Life Science Summit will take place in Lund on November 20-21. CEO Laura Chirica will present Cellevate to industry leaders, specialist investors and potential partners.The Summit connects innovation and capital, providing small-to-medium size Nordic companies from a wide range of therapeutic areas the platform and opportunity to make their case to both Swedish and international investors as well as top-level potential partners in a unique boutique setting.    Date: 21 November Time: 11:05  Location: Auditorium at Medicon Village, Lund Read

There are no items matching the current filter
There are no more items matching the current filter
Back to top